Jonathan E. Rosenberg, M.D.
Director
Dana-Farber/Brigham and Women’s Hospital Bladder Cancer Center

Jonathan E. Rosenberg, M.D., is the Clinical Director of the Lank Center for Genitourinary Oncology and the Director of the Dana-Farber/Brigham and Women’s Hospital Bladder Cancer Center. He is also an Assistant Professor at Harvard Medical School.  Dr. Rosenberg is also a member of the Cancer and Leukemia Group B Genitourinary Oncology Core Committee, and leads the bladder cancer cadre. Dr. Rosenberg works closely with the Dana-Farber clinical administration to coordinate patient care for urologic oncology patients and supervise the clinical staff of the Lank Center.

Dr. Rosenberg’s awards and honors include a 2009 Dunkin Donuts Rising Star Award. He has led many multi-institutional trials in bladder and prostate cancer.  He is a member of the American Society of Clinical Oncology and an Editorial Board Member of the Journal of Clinical Oncology.

Dr. Rosenberg received his BS from Duke University and his MD from Harvard Medical School.  He completed an internship and residency in Internal Medicine at New York Presbyterian Hospital-Cornell and completed a clinical fellowship in Hematology/Oncology at the University of California Medical Center where he had been on the faculty for 5 years before joining the Dana Farber Cancer Institute.

Click here for more information.